Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (81-90 of 287) with videos related to

Pageof 29
Sort By:
The International Journal of Biological Markers|July 5, 2003
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancerP Lissoni, F Rovelli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancerP Lissoni, S Pittalis, F Rovelli, et al.
British Journal of Cancer|July 17, 1998
In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patientsP Lissoni, L Fumagalli, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1995
Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
The International Journal of Biological Markers|April 1, 1995
Zinc levels in serum during subcutaneous interleukin-2 immunotherapy of cancerP Lissoni, V Arosio, E Mocchegiani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasmsP Lissoni, S Meregalli, E Bonetto, et al.
Tumori|December 31, 1988
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary studyF Rovelli, P Lissoni, S Crispino, et al.
Oncology|January 1, 1991
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapiesP Lissoni, S Barni, G Cattaneo, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1996
Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretionP Lissoni, F Rovelli, L Giani, et al.
Pageof 29

Showing results (81-90 of 287) with videos related to

Sort By:
Pageof 29
The International Journal of Biological Markers|July 5, 2003
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancerP Lissoni, F Rovelli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancerP Lissoni, S Pittalis, F Rovelli, et al.
British Journal of Cancer|July 17, 1998
In vivo stimulation of IL-12 secretion by subcutaneous low-dose IL-2 in metastatic cancer patientsP Lissoni, L Fumagalli, F Rovelli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1995
Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patientsP Lissoni, S Barni, A Ardizzoia, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
The International Journal of Biological Markers|April 1, 1995
Zinc levels in serum during subcutaneous interleukin-2 immunotherapy of cancerP Lissoni, V Arosio, E Mocchegiani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 11, 2006
Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasmsP Lissoni, S Meregalli, E Bonetto, et al.
Tumori|December 31, 1988
Increased level of soluble interleukin-2 receptor in advanced solid tumors: a preliminary studyF Rovelli, P Lissoni, S Crispino, et al.
Oncology|January 1, 1991
Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapiesP Lissoni, S Barni, G Cattaneo, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1996
Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretionP Lissoni, F Rovelli, L Giani, et al.
Pageof 29